Large-scale testing (Phase 3)UnknownNCT05165290
What this trial is testing
Prospective, Double-masked, Randomized, Multi-center, Active-controlled, Parallel-group, 3-month Study Assessing the Safety & Ocular Hypotensive Efficacy of TC-002 Ophthalmic Solution Compared to Latanoprost Ophthalmic Solution 0.005% in Subjects With Elevated Intraocular Pressure
Who this might be right for
Elevated Intraocular Pressure
TearClear Corp 300